Evidence map›Paper›PMID 41741921›Full record

ReviewCurrent nutrition reports2026

From Husks and Seeds to Health: an Inevitable Outcome Rather than a Fluke.

Nevin Sanlier, Ebru Ozler

Abstract readReview
In one paragraph

Review in Current nutrition reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nevin SanlierDepartment of Nutrition and Dietetics, School of Health Sciences, Ankara Medipol University, Altındağ, Ankara, 06050, Turkey. nevintekgul@gmail.com.ORCID http://orcid.org/0000-0001-5937-0485
Ebru OzlerDepartment of Nutrition and Dietetics, School of Health Sciences, Ankara Medipol University, Altındağ, Ankara, 06050, Turkey.ORCID http://orcid.org/0009-0000-3303-3077

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThis review was conducted to examine the promising health benefits of psyllium, its therapeutic potential in relation to various chronic diseases, its mechanisms, and its possible side effects or toxicity; to explore its applications in food systems; to identify the positive and negative effects of its consumption; and to provide perspectives for future research and development efforts for psyllium. RECENT

findingsPsyllium, also known as ispaghula, is a dietary fiber obtained from the shells of Plantago ovata seeds. The most abundant monosaccharides in its composition are xylose and arabinose. Psyllium is a natural alternative to the use of food additives such as gum and hydrocolloid to increase the fiber content in fortified foods. Psyllium may have therapeutic effects on various diseases. In recent years, its potential in the management of conditions such as hypertension, diabetes, and liver disease has been emphasized and multifaceted therapeutic applications have been introduced. Psyllium may help to regulate blood glucose, blood pressure and cholesterol levels. It may also increase feelings of fullness and reduce food intake. Furthermore, psyllium may promote bowel regularity and improve the composition of gut microbiota. Psyllium has been reported to exhibit antioxidant and antimicrobial properties, as well as reducing inflammatory mediators such as TNF-α and nitric oxide. Furthermore, psyllium has been associated with lower creatinine and uric acid levels, as well as a reduced risk of carcinogenesis. Studies in the literature support the therapeutic effects of psyllium. However, longer-term clinical trials are needed to determine the effective dose and duration of use. Innovative product development studies should be conducted to enhance the functional benefits of psyllium in the food industry.

Indexed as

ConstipationDiabetesDietary fiberObesityPsyllium

Identifiers

PMID41741921
PMCPMC12935724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.